Oxford Malaria Vaccine Trial Points to Disease ‘Game-Changer’
Bloomberg 1 hr ago Janice Kew
(Bloomberg) The first malaria vaccine to meet a World Health Organization specified goal of more than 75% efficacy has been developed by scientists at the University of Oxford, a potentially significant step toward defeating the disease.
Finding more effective inoculations against the mosquito-borne disease has been a critical goal in fighting an infection that kills about 400,000 people a year, largely in sub-Saharan Africa, with most being children under the age of five.
“Even before COVID-19, progress in the global fight against malaria had stalled,” said Simon Bland, chief executive officer of the Global Institute for Disease Elimination. “This new vaccine could be a game-changer toward the elimination of malaria, a disease that has killed more people than any other since the beginning of humankind.”
Ancient killer vs novel threat: how the fights against malaria and Covid-19 compare
Eradicating malaria remains out-of-reach, despite a vaccine breakthrough. Why are we closer to beating Covid than this age-old threat?
23 April 2021 • 2:21pm
Malaria killed up to 300 million people in the 20th century - roughly the same number each year as Covid-19 has killed since the pandemic began
Credit: Christina Aldehuela/AFP
It is thought to be one of the oldest diseases in the world, dating back to before the dawn of humanity. And while some parts of the globe have successfully beaten it, for others it is a constant burden.
Mideast refugees left behind in COVID-19 vaccine race
Syrian and Jordanian women working in a garment factory in one of Jordan s industrial zones. COVAX has allocated funds for humanitarian needs, and vaccination has begun in Zaatari refugee camp in Jordan. Copyright: Abdel Hameed Al Nasier/ILO, (CC BY-NC-ND 2.0)
Speed read
But challenges remain to reach those in remote conflict areas
More must be done to close gaps in vaccine distribution, say experts
Share this article:
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
Press release content from Business Wire. The AP news staff was not involved in its creation.
GLIDE-Carter Center Partnership Aims to Eliminate River Blindness in the Americas, Lymphatic Filariasis and Malaria on Hispaniola
March 7, 2021 GMT
ATLANTA & ABU DHABI, United Arab Emirates (BUSINESS WIRE) Mar 6, 2021
The Carter Center and The Global Institute for Disease Elimination (GLIDE) announced an exciting new partnership to support the Carter Center’s innovative disease elimination efforts in the Americas.
GLIDE, an initiative of the Crown Prince Court of Abu Dhabi and the Bill & Melinda Gates Foundation, has pledged substantial financial and technological support for the Center’s programs to eliminate two neglected diseases: river blindness (onchocerciasis) in the Amazon rainforest along the Brazil-Venezuela border and lymphatic filariasis (commonly called LF or elephantiasis) throughout Hispaniola, the island shared by Haiti and the Dominican Republic. The initiative also
Redirecting to GLIDE-Carter Center Partnership Aims to Eliminate River Blindness in the Americas, Lymphatic Filariasis and Malaria on Hispaniola q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.